세계의 원내 요로 감염 시장 2019

가 발행한 조사보고서이며, 코드는  입니다.■ 상품코드 :
■ 조사/발행회사 :
■ 발행일 :
■ 페이지수 : n/a
■ 작성언어 :
■ 보고서 형태 :
■ 납품 방식 :
■ 판매가격 / 옵션 (부가세별도)
0 ⇒환산₩원화가격은 문의주세요.견적의뢰/주문/질문
가격옵션 설명
- 지불하실 금액은 상기 원화금액에 부가세(10%)를 더한 금액입니다.
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제이며, 세금계산서 발행 가능합니다.
■ 보고서 개요

Hospital acquired urinary tract infections are caused by patients urethral catheters or invasive manipulation in the urogenital tract, which allows microbes to enter into the bladder and encourages proliferation by providing a sustainable environment.
They are accountable for over 50% of infections.
An array of tests can uncover type of infection and pathogen associated with the infection to efficiently treat the infected area.
Increase in prevalence of hospital acquired UTIs and technological advancement in testing devices drive the market.

The global Hospital Acquired Urinary Tract Infection market was valued at xx million US$ in 2018 and will reach xx million US$ by the end of 2025, growing at a CAGR of xx% during 2019-2025.
This report focuses on Hospital Acquired Urinary Tract Infection volume and value at global level, regional level and company level. From a global perspective, this report represents overall Hospital Acquired Urinary Tract Infection market size by analyzing historical data and future prospect.
Regionally, this report categorizes the production, apparent consumption, export and import of Hospital Acquired Urinary Tract Infection in North America, Europe, China, Japan, Southeast Asia and India.
For each manufacturer covered, this report analyzes their Hospital Acquired Urinary Tract Infection manufacturing sites, capacity, production, ex-factory price, revenue and market share in global market.

The following manufacturers are covered:
Advanced Sterilization Products
Becton
Dickinson and Company
Steris Corporation
Getinge Group
Kimberly-Clark Corporation
Cantel Medical
Biomerieux
Belimed
3M Company
Sterigenics International
Synergy Health
PLC

Segment by Regions
North America
Europe
China
Japan
Southeast Asia
India

Segment by Type
Microbial Testing Instruments
Reagents and Consumables
Infection Prevention and Surveillance Software

Segment by Application
Disease Testing
Drug-resistance Testing

■ 보고서 목차

Table of Contents

Executive Summary
1 Industry Overview of Hospital Acquired Urinary Tract Infection
1.1 Definition of Hospital Acquired Urinary Tract Infection
1.2 Hospital Acquired Urinary Tract Infection Segment by Type
1.2.1 Global Hospital Acquired Urinary Tract Infection Production Growth Rate Comparison by Types (2014-2025)
1.2.2 Microbial Testing Instruments
1.2.3 Reagents and Consumables
1.2.4 Infection Prevention and Surveillance Software
1.3 Hospital Acquired Urinary Tract Infection Segment by Applications
1.3.1 Global Hospital Acquired Urinary Tract Infection Consumption Comparison by Applications (2014-2025)
1.3.2 Disease Testing
1.3.3 Drug-resistance Testing
1.4 Global Hospital Acquired Urinary Tract Infection Overall Market
1.4.1 Global Hospital Acquired Urinary Tract Infection Revenue (2014-2025)
1.4.2 Global Hospital Acquired Urinary Tract Infection Production (2014-2025)
1.4.3 North America Hospital Acquired Urinary Tract Infection Status and Prospect (2014-2025)
1.4.4 Europe Hospital Acquired Urinary Tract Infection Status and Prospect (2014-2025)
1.4.5 China Hospital Acquired Urinary Tract Infection Status and Prospect (2014-2025)
1.4.6 Japan Hospital Acquired Urinary Tract Infection Status and Prospect (2014-2025)
1.4.7 Southeast Asia Hospital Acquired Urinary Tract Infection Status and Prospect (2014-2025)
1.4.8 India Hospital Acquired Urinary Tract Infection Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis
2.1 Raw Material and Suppliers
2.2 Manufacturing Cost Structure Analysis of Hospital Acquired Urinary Tract Infection
2.3 Manufacturing Process Analysis of Hospital Acquired Urinary Tract Infection
2.4 Industry Chain Structure of Hospital Acquired Urinary Tract Infection

3 Development and Manufacturing Plants Analysis of Hospital Acquired Urinary Tract Infection
3.1 Capacity and Commercial Production Date
3.2 Global Hospital Acquired Urinary Tract Infection Manufacturing Plants Distribution
3.3 Major Manufacturers Technology Source and Market Position of Hospital Acquired Urinary Tract Infection
3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers
4.1 Hospital Acquired Urinary Tract Infection Production and Capacity Analysis
4.2 Hospital Acquired Urinary Tract Infection Revenue Analysis
4.3 Hospital Acquired Urinary Tract Infection Price Analysis
4.4 Market Concentration Degree

5 Hospital Acquired Urinary Tract Infection Regional Market Analysis
5.1 Hospital Acquired Urinary Tract Infection Production by Regions
5.1.1 Global Hospital Acquired Urinary Tract Infection Production by Regions
5.1.2 Global Hospital Acquired Urinary Tract Infection Revenue by Regions
5.2 Hospital Acquired Urinary Tract Infection Consumption by Regions
5.3 North America Hospital Acquired Urinary Tract Infection Market Analysis
5.3.1 North America Hospital Acquired Urinary Tract Infection Production
5.3.2 North America Hospital Acquired Urinary Tract Infection Revenue
5.3.3 Key Manufacturers in North America
5.3.4 North America Hospital Acquired Urinary Tract Infection Import and Export
5.4 Europe Hospital Acquired Urinary Tract Infection Market Analysis
5.4.1 Europe Hospital Acquired Urinary Tract Infection Production
5.4.2 Europe Hospital Acquired Urinary Tract Infection Revenue
5.4.3 Key Manufacturers in Europe
5.4.4 Europe Hospital Acquired Urinary Tract Infection Import and Export
5.5 China Hospital Acquired Urinary Tract Infection Market Analysis
5.5.1 China Hospital Acquired Urinary Tract Infection Production
5.5.2 China Hospital Acquired Urinary Tract Infection Revenue
5.5.3 Key Manufacturers in China
5.5.4 China Hospital Acquired Urinary Tract Infection Import and Export
5.6 Japan Hospital Acquired Urinary Tract Infection Market Analysis
5.6.1 Japan Hospital Acquired Urinary Tract Infection Production
5.6.2 Japan Hospital Acquired Urinary Tract Infection Revenue
5.6.3 Key Manufacturers in Japan
5.6.4 Japan Hospital Acquired Urinary Tract Infection Import and Export
5.7 Southeast Asia Hospital Acquired Urinary Tract Infection Market Analysis
5.7.1 Southeast Asia Hospital Acquired Urinary Tract Infection Production
5.7.2 Southeast Asia Hospital Acquired Urinary Tract Infection Revenue
5.7.3 Key Manufacturers in Southeast Asia
5.7.4 Southeast Asia Hospital Acquired Urinary Tract Infection Import and Export
5.8 India Hospital Acquired Urinary Tract Infection Market Analysis
5.8.1 India Hospital Acquired Urinary Tract Infection Production
5.8.2 India Hospital Acquired Urinary Tract Infection Revenue
5.8.3 Key Manufacturers in India
5.8.4 India Hospital Acquired Urinary Tract Infection Import and Export

6 Hospital Acquired Urinary Tract Infection Segment Market Analysis (by Type)
6.1 Global Hospital Acquired Urinary Tract Infection Production by Type
6.2 Global Hospital Acquired Urinary Tract Infection Revenue by Type
6.3 Hospital Acquired Urinary Tract Infection Price by Type

7 Hospital Acquired Urinary Tract Infection Segment Market Analysis (by Application)
7.1 Global Hospital Acquired Urinary Tract Infection Consumption by Application
7.2 Global Hospital Acquired Urinary Tract Infection Consumption Market Share by Application (2014-2019)

8 Hospital Acquired Urinary Tract Infection Major Manufacturers Analysis
8.1 Advanced Sterilization Products
8.1.1 Advanced Sterilization Products Hospital Acquired Urinary Tract Infection Production Sites and Area Served
8.1.2 Advanced Sterilization Products Product Introduction, Application and Specification
8.1.3 Advanced Sterilization Products Hospital Acquired Urinary Tract Infection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.1.4 Main Business and Markets Served
8.2 Becton
8.2.1 Becton Hospital Acquired Urinary Tract Infection Production Sites and Area Served
8.2.2 Becton Product Introduction, Application and Specification
8.2.3 Becton Hospital Acquired Urinary Tract Infection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.2.4 Main Business and Markets Served
8.3 Dickinson and Company
8.3.1 Dickinson and Company Hospital Acquired Urinary Tract Infection Production Sites and Area Served
8.3.2 Dickinson and Company Product Introduction, Application and Specification
8.3.3 Dickinson and Company Hospital Acquired Urinary Tract Infection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.3.4 Main Business and Markets Served
8.4 Steris Corporation
8.4.1 Steris Corporation Hospital Acquired Urinary Tract Infection Production Sites and Area Served
8.4.2 Steris Corporation Product Introduction, Application and Specification
8.4.3 Steris Corporation Hospital Acquired Urinary Tract Infection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.4.4 Main Business and Markets Served
8.5 Getinge Group
8.5.1 Getinge Group Hospital Acquired Urinary Tract Infection Production Sites and Area Served
8.5.2 Getinge Group Product Introduction, Application and Specification
8.5.3 Getinge Group Hospital Acquired Urinary Tract Infection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.5.4 Main Business and Markets Served
8.6 Kimberly-Clark Corporation
8.6.1 Kimberly-Clark Corporation Hospital Acquired Urinary Tract Infection Production Sites and Area Served
8.6.2 Kimberly-Clark Corporation Product Introduction, Application and Specification
8.6.3 Kimberly-Clark Corporation Hospital Acquired Urinary Tract Infection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.6.4 Main Business and Markets Served
8.7 Cantel Medical
8.7.1 Cantel Medical Hospital Acquired Urinary Tract Infection Production Sites and Area Served
8.7.2 Cantel Medical Product Introduction, Application and Specification
8.7.3 Cantel Medical Hospital Acquired Urinary Tract Infection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.7.4 Main Business and Markets Served
8.8 Biomerieux
8.8.1 Biomerieux Hospital Acquired Urinary Tract Infection Production Sites and Area Served
8.8.2 Biomerieux Product Introduction, Application and Specification
8.8.3 Biomerieux Hospital Acquired Urinary Tract Infection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.8.4 Main Business and Markets Served
8.9 Belimed
8.9.1 Belimed Hospital Acquired Urinary Tract Infection Production Sites and Area Served
8.9.2 Belimed Product Introduction, Application and Specification
8.9.3 Belimed Hospital Acquired Urinary Tract Infection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.9.4 Main Business and Markets Served
8.10 3M Company
8.10.1 3M Company Hospital Acquired Urinary Tract Infection Production Sites and Area Served
8.10.2 3M Company Product Introduction, Application and Specification
8.10.3 3M Company Hospital Acquired Urinary Tract Infection Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
8.10.4 Main Business and Markets Served
8.11 Sterigenics International
8.12 Synergy Health
8.13 PLC

9 Development Trend of Analysis of Hospital Acquired Urinary Tract Infection Market
9.1 Global Hospital Acquired Urinary Tract Infection Market Trend Analysis
9.1.1 Global Hospital Acquired Urinary Tract Infection Market Size (Volume and Value) Forecast 2019-2025
9.2 Hospital Acquired Urinary Tract Infection Regional Market Trend
9.2.1 North America Hospital Acquired Urinary Tract Infection Forecast 2019-2025
9.2.2 Europe Hospital Acquired Urinary Tract Infection Forecast 2019-2025
9.2.3 China Hospital Acquired Urinary Tract Infection Forecast 2019-2025
9.2.4 Japan Hospital Acquired Urinary Tract Infection Forecast 2019-2025
9.2.5 Southeast Asia Hospital Acquired Urinary Tract Infection Forecast 2019-2025
9.2.6 India Hospital Acquired Urinary Tract Infection Forecast 2019-2025
9.3 Hospital Acquired Urinary Tract Infection Market Trend (Product Type)
9.4 Hospital Acquired Urinary Tract Infection Market Trend (Application)

10.1 Marketing Channel
10.1.1 Direct Marketing
10.1.2 Indirect Marketing
10.3 Hospital Acquired Urinary Tract Infection Customers

11 Market Dynamics
11.1 Market Trends
11.2 Opportunities
11.3 Market Drivers
11.4 Challenges
11.5 Influence Factors

12 Conclusion
13 Appendix
13.1 Methodology/Research Approach
13.1.1 Research Programs/Design
13.1.2 Market Size Estimation
13.1.3 Market Breakdown and Data Triangulation
13.2 Data Source
13.2.1 Secondary Sources
13.2.2 Primary Sources
13.3 Author List
13.4 Disclaimer

※본 조사보고서 [세계의 원내 요로 감염 시장 2019] (코드 : ) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [세계의 원내 요로 감염 시장 2019] 에 대해서 E메일 문의는 여기를 클릭하세요.